Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP625357.RA5ogqmqVRbwnEtwB0lsXt5vsLxt0NMMj2P-AS65Drq78130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP625357.RA5ogqmqVRbwnEtwB0lsXt5vsLxt0NMMj2P-AS65Drq78130_assertion type Assertion NP625357.RA5ogqmqVRbwnEtwB0lsXt5vsLxt0NMMj2P-AS65Drq78130_head.
- NP625357.RA5ogqmqVRbwnEtwB0lsXt5vsLxt0NMMj2P-AS65Drq78130_assertion description "[The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in the growth and survival of hematologic malignancies and inhibition of this pathway is considered as a therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625357.RA5ogqmqVRbwnEtwB0lsXt5vsLxt0NMMj2P-AS65Drq78130_provenance.
- NP625357.RA5ogqmqVRbwnEtwB0lsXt5vsLxt0NMMj2P-AS65Drq78130_assertion evidence source_evidence_literature NP625357.RA5ogqmqVRbwnEtwB0lsXt5vsLxt0NMMj2P-AS65Drq78130_provenance.
- NP625357.RA5ogqmqVRbwnEtwB0lsXt5vsLxt0NMMj2P-AS65Drq78130_assertion SIO_000772 16645590 NP625357.RA5ogqmqVRbwnEtwB0lsXt5vsLxt0NMMj2P-AS65Drq78130_provenance.
- NP625357.RA5ogqmqVRbwnEtwB0lsXt5vsLxt0NMMj2P-AS65Drq78130_assertion wasDerivedFrom befree-20150227 NP625357.RA5ogqmqVRbwnEtwB0lsXt5vsLxt0NMMj2P-AS65Drq78130_provenance.
- NP625357.RA5ogqmqVRbwnEtwB0lsXt5vsLxt0NMMj2P-AS65Drq78130_assertion wasGeneratedBy ECO_0000203 NP625357.RA5ogqmqVRbwnEtwB0lsXt5vsLxt0NMMj2P-AS65Drq78130_provenance.